Amuvatinib (MP-470)

Name: Amuvatinib (MP-470); MyBioSource
Brand: MyBioSource
SKU: MBS3606179
Price: 240 USD
Availability: InStock
Rating: 5 (10 reviews)

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS3606179

A novel RTK inhibitor that effectively inhibits c-Kit, PDGFRalpha and Flt3 with IC50 of 10 nM, 40 nM and 81 nM, respectively. More details

$240 / 2 mg +1 FREE 8GB USB

Product Documentation

Sample Manual Insert View PDF

Testing Data View PDF

Certificate of Analysis (COA) View PDF

QC Report View PDF

Material Safety Data Sheet View PDF

Technical Datasheet View PDF

Protocol View PDF

Product Overview

Online Datasheet in PDF

Product Name

Amuvatinib, Biochemical

Full Product Name

Amuvatinib

Product Synonym Names

MP-470; MP 470; MP470; HPK-56; HPK56

Purity/Purification

>98% (HPLC)

Preparation and Storage

Store at -20 degree C
Stability: >=2 years
Shipping: Ice Pack

Molecular Weight

447.5096

Suitability

10mM in DMSO

Target

c-Kit

Receptor

c-Kit (D816H); FLT3 (D835Y); PDGFRalpha (V561D)

Chemical Name

1-Piperazinecarbothioamide, N-(1, 3-benzodioxol-5-ylmethyl)-4-benzofuro[3, 2-d]pyrimidin-4-yl

SMILES

S=C(N1CCN(C2=C(OC3=CC=CC=C34)C4=NC=N2)CC1)NCC5=CC=C(OCO6)C6=C5

Molecular Formula

C23H21N5O3S

CAS Number

850879-09-3

Product Categories/Family for Amuvatinib biochemical

Lung Cancer; Angiogenesis; Cancer

Product References and Citations for Amuvatinib biochemical

1. Mahadevan D, et al. Oncogene. 2007 Jun 7; 26 (27):3909-19.
2. Qi W, et al. BMC Cancer. 2009 May 11; 9:142.
4. Bearss DJ, et al. US Patent, US/2008/0226747.

Other Notes

Small volumes of Amuvatinib biochemical vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Amuvatinib purchase

MBS3606179 is a biochemical targeting Amuvatinib.